Dietary inflammatory index and sarcopenia: a systematic review and meta-analysis.
Dietary inflammatory potential may be associated with sarcopenia, but evidence is heterogeneous. We systematically reviewed associations of the Dietary Inflammatory Index (DII) and energy-adjusted DII (E-DII) with sarcopenia-related outcomes in adults.
PubMed, Embase, and Web of Science were searched through 31 August 2026. Random-effects meta-analyses prioritized confirmed sarcopenia.
Forty-seven eligible studies were included; 16 contributed to quantitative syntheses and six were prospective. In eight cross-sectional studies, the highest versus lowest DII/E-DII category was associated with greater odds of confirmed sarcopenia (OR = 1.75, 95% CI 1.37-2.24; I 2=38.5%; 95% prediction interval 1.03-2.99).
Four studies contributed to per-unit analysis (OR = 1.37, 95% CI 1.25-1.51; I 2=0%; prediction interval 1.12-1.68). Component-specific evidence extended to muscle strength and physical performance.
Exploratory Egger regression indicated funnel-plot asymmetry; trim-and-fill attenuated the primary categorical OR to 1.48 (95% CI 1.24-1.77) and the broad categorical OR to 1.53 (95% CI 1.34-1.76). Certainty was very low.
Greater dietary inflammatory potential was associated with confirmed sarcopenia, but predominantly cross-sectional evidence, heterogeneous longitudinal findings, and potential small-study effects limit causal interpretation. Clinical application is premature; prospective cohorts with repeated dietary assessment and standardized outcomes, and intervention trials, are needed.
